Treatment with somatostatin analogs and chemoembolization of liver metastases for severe hypoglycemia in malignant insulinomas.
Jean-Christophe Maïza(Hôpital Rangueil), Philippe Caron(Hôpital Larrey), Rosine Guimbaud(Canadian Partnership Against Cancer), Philippe Otal(Hôpital Rangueil), A. Bennet, Solange Grunenwald(Hôpital Larrey), Delphine Vezzosi(Université Toulouse III - Paul Sabatier)
Cited by 15
Related Papers
Constitutive Activation of PKA Catalytic Subunit in Adrenal Cushing's Syndrome
|New England Journal of Medicine|2014|434
Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
|JAMA Oncology|2022|336
Ketoconazole in Cushing's Disease: Is It Worth a Try?
|The Journal of Clinical Endocrinology & Metabolism|2014|288
Prognostic factors in stage III–IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study
|Annals of Oncology|2015|257
Octreotide in insulinoma patients: efficacy on hypoglycemia, relationships with Octreoscan scintigraphy and immunostaining with anti-sst2A and anti-sst5 antibodies
|European Journal of Endocrinology|2005|183